Notice2021-18539
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 27, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 164 (Friday, August 27, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Pages 48144-48145]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-18539]
[[Page 48144]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-1102]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Tuberculosis Data from Panel Physicians to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on May 26, 2021 to obtain comments
from the public and affected agencies. CDC received one non-substantive
comment related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Tuberculosis Data from Panel Physicians (OMB Control No. 0920-1102,
Exp. 9/30/2021)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ), Immigrant, Refugee, and
Migrant Health Branch (IRMH), requests approval for a Revision to an
approved information collection. The respondents are U.S. panel
physicians. Panel physicians are medically trained, licensed, and
experienced medical doctors practicing overseas who are appointed by
the local U.S. Embassy or Consulate General to perform medical
examinations for prospective immigrants to the United States. More than
760 panel physicians perform overseas pre-departure medical
examinations at 336 panel sites, in accordance with requirements,
referred to as Technical Instructions, provided by the Centers for
Disease Control and Prevention's Division of Global Migration and
Quarantine, Quality Assessment Program (QAP). The QAP program is housed
in the Immigrant, Refugee, and Migrant Health Branch (IRMH). The role
of QAP is to assist and guide panel physicians in the implementation of
the Technical Instructions; evaluate the quality of the overseas
medical examination for U.S.-bound immigrants and refugees; assess
potential panel physician sites; and provide recommendations to the
U.S. Department of State in matters of immigrant medical screening.
To achieve DGMQ's mission, IRMH works with domestic and
international programs to improve the health of U.S.-bound immigrants
and refugees to protect the U.S. public by preventing the importation
of infectious disease. These goals are accomplished through IRMH's
oversight of medical exams required for all U.S.-bound immigrants and
refugees who seek permanent residence in the U.S. IRMH is responsible
for assisting and training the international panel physicians with the
implementation of medical exam Technical Instructions. CDC's Technical
Instructions are detailed requirements and national policies regarding
the medical screening and treatment of all U.S.-bound immigrants and
refugees.
Screening for tuberculosis (TB) is a particularly important
component of the immigration medical exam and allows panel physicians
to diagnose active TB disease prior to arrival in the United States. As
part of the Technical Instructions requirements, panel physicians
perform chest x-rays and laboratory tests that aid in the
identification of tuberculosis infection (Class B1 applicants) and
diagnosis of active tuberculosis disease (Class A, inadmissible
applicants). CDC uses these classifications to report new immigrant and
refugee arrivals with a higher risk of developing TB disease to U.S.
state and local health departments for further follow-up. Some
information that panel physicians collect as part of the medical exam
is not reported on the standard Department of State forms (DS-forms),
thereby preventing CDC from evaluating TB trends in globally mobile
populations and monitoring program effectiveness.
In 2007, CDC revised the Tuberculosis Technical Instructions to
include several new requirements for Mycobacteria tuberculosis (MTB)
testing and treatment. Important changes included the requirements for:
(1) Sputum cultures in addition to sputum smears; (2) tuberculin skin
tests or interferon gamma release assays (beginning in 2009) for
certain children aged 2-14 years examined in countries where the World
Health Organization estimated TB incidence is >=20 per 100,000 persons;
(3) drug-susceptibility testing of positive isolates; and (4) treatment
being delivered as directly observed therapy (DOT) throughout the
entire course.
Since implementation of these new Culture and Directly Observed
Therapy TB Technical Instructions (CDOT TB TI), overseas TB case
detection has increased by an estimated 60% and allowed U.S. public
health programs to save millions of dollars annually. Overseas TB
screening data (referred to by DGMQ as `TB Indicator data') is critical
to support the continued analysis of these trends and the monitoring of
TB control efforts in the U.S.
CDC requests this data collection approval for three years. This
Revision includes a decrease in respondents from 336 to 333, and a
decrease in the requested number of burden hours from
[[Page 48145]]
1,008 hours to 999. There is no cost to respondents other than their
time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
International Panel Physicans......... TB Indicators REDCap web 333 1 3
form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-18539 Filed 8-26-21; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on August 27, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.